Hrynkow Sharon Hemond 4
4 · Cyclo Therapeutics, Inc. · Filed Aug 30, 2021
Insider Transaction Report
Form 4
Hrynkow Sharon Hemond
SVP for Medical Affairs
Transactions
- Award
Stock Option (Right to buy)
2021-08-27+23,800→ 23,800 totalExercise: $7.46Exp: 2031-08-27→ Common Stock (23,800 underlying)
Footnotes (1)
- [F1]The option vests over a four year period in equal monthly installments.